Paige leverages AI and machine learning to better map the pathology of cancer. The company builds computational pathology products designed to allow patients and their healthcare teams to make more informed treatment decisions.
The company was founded by an impressive set of medical professionals – including Dr Thomas Fuchs, who is known for his work on computational pathology. It continues to grow thanks to a collective of specialists in pathology, machine learning, healthcare, and business.
Paige closed out its Series B funding at $70 million, which takes total fundraising to $195 million. This new investment puts them in a prime position to expand into the global digital pathology market, which is expected to reach revenues of $1.27 billion by 2026. The company is now investing in sales and marketing efforts, as well as doubling the number of employees.
Kirsty
Company Specialist at Welcome to the Jungle